Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9051 |
High Similarity |
NPD2801 |
Approved |
0.8938 |
High Similarity |
NPD3882 |
Suspended |
0.875 |
High Similarity |
NPD1934 |
Approved |
0.858 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD3818 |
Discontinued |
0.8545 |
High Similarity |
NPD5494 |
Approved |
0.8512 |
High Similarity |
NPD7473 |
Discontinued |
0.8503 |
High Similarity |
NPD3926 |
Phase 2 |
0.8481 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8452 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8452 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8383 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8375 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8364 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8313 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8304 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8256 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8198 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8193 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.815 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8133 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8114 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8086 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD919 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7949 |
Intermediate Similarity |
NPD943 |
Approved |
0.7944 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD6799 |
Approved |
0.791 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7901 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7898 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7882 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7844 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD920 |
Approved |
0.7765 |
Intermediate Similarity |
NPD5402 |
Approved |
0.775 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7719 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7673 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7657 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7544 |
Intermediate Similarity |
NPD37 |
Approved |
0.7541 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7528 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7473 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7421 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7401 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7356 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7353 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7296 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7293 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7283 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7229 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7213 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7167 |
Intermediate Similarity |
NPD5242 |
Approved |
0.716 |
Intermediate Similarity |
NPD3764 |
Approved |
0.716 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7122 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7102 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.71 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.71 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7074 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7024 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7017 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7005 |
Intermediate Similarity |
NPD7697 |
Approved |
0.6994 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD6385 |
Approved |
0.6989 |
Remote Similarity |
NPD6386 |
Approved |
0.6977 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6971 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD5408 |
Approved |
0.6964 |
Remote Similarity |
NPD5404 |
Approved |
0.6964 |
Remote Similarity |
NPD5406 |
Approved |
0.6964 |
Remote Similarity |
NPD5405 |
Approved |
0.6959 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD1470 |
Approved |
0.6954 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6928 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6914 |
Remote Similarity |
NPD2798 |
Approved |
0.6882 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6881 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6881 |
Remote Similarity |
NPD7874 |
Approved |
0.6875 |
Remote Similarity |
NPD9717 |
Approved |
0.6875 |
Remote Similarity |
NPD1608 |
Approved |
0.6872 |
Remote Similarity |
NPD4288 |
Approved |
0.6871 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6868 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6867 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6862
|
Remote Similarity |
NPD7549 |
Discontinued |